The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Facilitate Pharmacokinetic (PK) and Pharmacodynamic (PD) modeling and simulation with powerful tools for Nonlinear Mixed-Effects (NLME) modeling. The package provides access to the same advanced Maximum Likelihood algorithms used by the NLME-Engine in the Phoenix platform. These tools support a range of analyses, from parametric methods to individual and pooled data analysis <https://www.certara.com/app/uploads/2020/06/BR_PhoenixNLME-v4.pdf>. Execution is supported both locally or on remote machines.
| Version: | 3.0.1 |
| Depends: | R (≥ 4.0) |
| Imports: | xml2, assertthat, Certara.NLME8, data.table, jsonlite, methods, utils, ssh |
| Suggests: | rlang, knitr, rmarkdown, testthat, magrittr |
| Published: | 2024-11-20 |
| DOI: | 10.32614/CRAN.package.Certara.RsNLME |
| Author: | James Craig [aut, cre], Michael Tomashevskiy [aut], Vitalii Nazarov [aut], Shuhua Hu [ctb], Soltanshahi Fred [aut], Certara USA, Inc. [cph, fnd] |
| Maintainer: | James Craig <james.craig at certara.com> |
| License: | LGPL-3 |
| URL: | https://certara.github.io/R-RsNLME/ |
| NeedsCompilation: | no |
| Materials: | README |
| CRAN checks: | Certara.RsNLME results |
| Reference manual: | Certara.RsNLME.pdf |
| Package source: | Certara.RsNLME_3.0.1.tar.gz |
| Windows binaries: | r-devel: Certara.RsNLME_3.0.1.zip, r-release: not available, r-oldrel: not available |
| macOS binaries: | r-release (arm64): Certara.RsNLME_3.0.1.tgz, r-oldrel (arm64): Certara.RsNLME_3.0.1.tgz, r-release (x86_64): Certara.RsNLME_3.0.1.tgz, r-oldrel (x86_64): Certara.RsNLME_3.0.1.tgz |
Please use the canonical form https://CRAN.R-project.org/package=Certara.RsNLME to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.